|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 473.30 INR | +2.14% |
|
+9.46% | +7.24% |
| 05-23 | Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| 05-22 | Unichem Laboratories March-quarter consol profit 109.1 million rupees | RE |
| Market Cap | 20.68B 217M 190M 175M 163M 309M 313M 2.09B 814M 10.17B 815M 798M 35.03B | P/E 2024 |
-48.8x | P/E 2025 | 35.6x |
|---|---|---|---|---|---|
| Enterprise Value | 24.38B 256M 224M 206M 192M 364M 369M 2.47B 960M 11.99B 961M 941M 41.3B | EV / Sales 2024 |
2.07x | EV / Sales 2025 | 2.49x |
| Free-Float |
28.71% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.14% | ||
| 1 week | +9.46% | ||
| Current month | +1.92% | ||
| 1 month | +29.60% | ||
| 3 months | +58.59% | ||
| 6 months | +6.83% | ||
| Current year | +7.24% |
| 1 week | 427.3 |  | 487.15 |
| 1 month | 353.5 | | 515.55 |
| Current year | 280 | | 515.55 |
| 1 year | 280 | | 656.85 |
| 3 years | 280 | | 949.85 |
| 5 years | 197.5 | | 949.85 |
| 10 years | 75.1 | | 949.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 10/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 08/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 22/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 10/08/2023 |
| Director/Board Member | 57 | 10/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.14% | +9.46% | -19.32% | +26.47% | 343M | |
| +1.86% | +7.65% | +55.77% | +158.84% | 1,082B | |
| +3.57% | +7.42% | +69.09% | +58.92% | 633B | |
| +3.99% | +7.37% | +36.87% | +93.77% | 461B | |
| -0.35% | +1.85% | +31.30% | +24.86% | 339B | |
| -0.56% | +2.80% | +39.13% | +28.20% | 301B | |
| -0.08% | +1.52% | +29.96% | +42.13% | 292B | |
| -1.54% | +3.56% | -25.96% | -40.53% | 225B | |
| +3.55% | +6.05% | +26.04% | +68.52% | 202B | |
| +4.21% | +6.00% | +17.72% | +70.33% | 163B | |
| Average | +1.19% | +5.14% | +26.06% | +53.15% | 370.01B | |
| Weighted average by Cap. | +1.04% | +5.54% | +41.78% | +80.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.05B 179M 157M 144M 134M 254M 258M 1.73B 671M 8.38B 672M 658M 28.88B | 21.11B 222M 194M 178M 166M 315M 320M 2.14B 831M 10.38B 832M 814M 35.76B |
| Net income | -705M -7.4M -6.47M -5.95M -5.54M -10.51M -10.67M -71.39M -27.75M -346M -27.78M -27.19M -1.19B | 1.38B 14.44M 12.63M 11.6M 10.82M 20.51M 20.83M 139M 54.15M 676M 54.21M 53.05M 2.33B |
| Net Debt | 953M 10.01M 8.75M 8.04M 7.49M 14.21M 14.43M 96.5M 37.51M 468M 37.56M 36.75M 1.61B | 3.7B 38.88M 33.99M 31.24M 29.12M 55.22M 56.06M 375M 146M 1.82B 146M 143M 6.27B |
Employees
3,142
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/07/26 | ₹473.30 | +2.14% | 5,837 |
| 02/07/26 | ₹463.40 | -2.21% | 3,956 |
| 01/07/26 | ₹473.85 | +2.03% | 16,644 |
| 30/06/26 | ₹464.40 | +2.43% | 10,673 |
| 29/06/26 | ₹453.40 | +4.86% | 20,985 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
